The Pediatric Infectious Disease Journal · 2014 · 14 citations · 31 references
Life SciencesImmunologyInfectious DiseasesImmunizationLactationVirologyGastrointestinal ImmunologyLactation ImmunologyMilk MicrobiologyVirus-like Particle VaccinesBlockingBreast Milk AntibodiesBreast Milk ImmunityImmunoglobulin G In MilkNorovirus GastroenteritisNorovirus InfectionRecombinant Virus-like ParticlesVirus-like Particles
BACKGROUND: Norovirus GII.4 genotype is a leading cause of nonbacterial gastroenteritis in infants. Effective vaccines against noroviruses are not yet available, enhancing the interest of the protection mechanisms elicited by breast milk that may contain norovirus-specific antibodies and histo-blood group antigens. The aims of our study were to analyze norovirus GII.4-specific antibodies in breast milk and serum and to assess their blocking activity on recombinant norovirus virus-like particles (VLPs) binding to saliva. METHODS: Mature milk and serum from 108 mothers were analyzed for specific IgA to norovirus GII.4-2006b and for their blocking activity on the binding of norovirus GII.4-2006b VLPs to fucosyltransferase FUT2-positive and negative saliva. Norovirus GII.4-2006b-specific IgG antibodies were also analyzed in serum samples. RESULTS: Higher specific IgA titers were detected in mature milk (75%) than in serum samples (62%), showing a correlation between both results (ρ = 0.427, P = 0.000). However, only 56.3% of the serum samples contained norovirus-specific IgG. Almost all mature milk samples (99.1%) inhibited the binding of norovirus VLPs to FUT2-negative saliva; however, only 25% did so to FUT2-positive saliva (P = 0.000). Ninety percent of serum samples inhibited the binding of norovirus VLPs to FUT2-negative saliva. CONCLUSIONS: Breast milk inhibits norovirus GII.4-2006b VLPs binding to receptors in saliva, and anti-norovirus IgA antibodies are only partly responsible for this activity. The FUT2 status of the receptor seems to be a strong predictor of this effect, but more studies to ascertain the participation of histo-blood group antigens in the protection against norovirus infections elicited by breast milk are required.
31
Human susceptibility and resistance to Norwalk virus infection
Lisa C. Lindesmith, Christine L. Moe, Séverine Marionneau‐Lambot et al. · Nature Medicine · 2003 · 1.1K citations
Human milk is a source of lactic acid bacteria for the infant gut
Susana Langa, C. Reviriego, Esther Jimínez et al. · The Journal of Pediatrics · 2003 · 783 citations
Pengwei Huang, Tibor Farkas, Weiming Zhong et al. · Journal of Virology · 2005 · 414 citations